Vertex Pharmaceuticals Incorporated (VRTX) delivered a return of -2.55% over the past year. Since VRTX does not currently pay dividends, the total return equals the price-only return.

A $10,000 investment in Vertex Pharmaceuticals Incorporated one year ago would be worth $9,745 today, representing a loss of $255.

Vertex Pharmaceuticals Incorporated (VRTX) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends. For VRTX, the total return equals the price-only return.

No, Vertex Pharmaceuticals Incorporated (VRTX) underperformed the S&P 500 by 20.48 percentage points over the past year. VRTX delivered a total return of -2.55%, compared to the S&P 500's 17.94%. This means a passive S&P 500 index fund outperformed VRTX by 20.48pp during this period.

Vertex Pharmaceuticals Incorporated (VRTX) experienced a maximum drawdown of -28.66% over the past year, declining from its peak on 2025-03-17 to its trough on 2025-08-08. The stock has not yet fully recovered to its prior peak. Maximum drawdown measures the worst peak-to-trough decline and is an important risk metric for investors.

Vertex Pharmaceuticals Incorporated (VRTX) has delivered strong long-term returns with dividends reinvested. Over 10 years, the total return is 436.2% (18.3% CAGR) — $10,000 would have grown to $53,625. Over 20 years: 991.3% total return (12.7% CAGR) — $10,000 → $109,127. Over 30 years: 3254.5% total return (12.4% CAGR) — $10,000 → $335,453. Long-term investors benefit from compounding: dividends buy additional shares, which generate their own dividends, creating an exponential growth effect.

Vertex Pharmaceuticals Incorporated's best calendar year was 2000 with a total return of 280.7%. Its worst year was 2001 with a total return of -61.0%. This range shows the volatility investors should expect — the difference between the best and worst year is 341.7 percentage points.